Melatonin for Prevention of Kidney Injury
Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury
Rutgers, The State University of New Jersey
300 participants
Jun 5, 2023
INTERVENTIONAL
Conditions
Summary
This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Melatonin 5 mg capsule by mouth at bedtime
Placebo capsule by mouth at bedtime
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05084196